AFIB - Acutus Medical, Inc.
NASDAQ
->
Healthcare
->
Medical Devices
Carlsbad,
United States
Type: Equity
AFIB price evolution
AFIB
| (in millions $) | 31 Mar 2024 | 31 Dec 2023 | 30 Sep 2023 | 30 Jun 2023 |
|---|---|---|---|---|
| Current assets | ||||
| Cash | $18.46 | $26.2 | $31.11 | $30.06 |
| Short term investments | $1.5 | $3.23 | $14.38 | $31.46 |
| Net receivables | $7.75 | $11.35 | $8.95 | $7.67 |
| Inventory | $5.89 | $4.28 | $15.73 | $15.67 |
| Total current assets | $34.4 | $46.25 | $72.64 | $87.3 |
| Long term investments | ||||
| Property, plant & equipment | $3.85 | $4.01 | $9.97 | $10.78 |
| Goodwill & intangible assets | $1.43 | $1.48 | ||
| Total noncurrent assets | $7.26 | $7.71 | $12.09 | $12.99 |
| Total investments | $1.5 | $3.23 | $14.38 | $31.46 |
| Total assets | $41.67 | $53.96 | $84.73 | $100.3 |
| Current liabilities | ||||
| Accounts payable | $3.17 | $2.76 | $4.75 | $5.49 |
| Deferred revenue | ||||
| Short long term debt | $2.65 | $2.58 | $0.71 | $0.47 |
| Total current liabilities | $9.87 | $18.94 | $14.77 | $18.22 |
| Long term debt | $35.81 | $35.9 | $38.22 | $38.31 |
| Total noncurrent liabilities | $35.81 | $35.9 | $38.26 | $38.33 |
| Total debt | $38.47 | $38.48 | $38.93 | $38.78 |
| Total liabilities | $45.69 | $54.84 | $53.02 | $56.55 |
| Shareholders' equity | ||||
| Retained earnings | -$601.6 | -$599.98 | -$566.21 | -$552.98 |
| Other shareholder equity | -$0.87 | -$0.87 | -$0.95 | -$0.89 |
| Total shareholder equity | -$4.02 | -$0.88 | $31.71 | $43.74 |
| (in millions $) | 31 Dec 2023 | 31 Jan 2023 | 31 Dec 2021 | 31 Dec 2020 |
|---|---|---|---|---|
| Current assets | ||||
| Cash | $26.2 | $31.35 | $24.22 | $25.38 |
| Short term investments | $3.23 | $44.86 | $76.7 | $105.84 |
| Net receivables | $11.35 | $21.09 | $3.63 | $2.16 |
| Inventory | $4.28 | $13.33 | $16.41 | $12.96 |
| Total current assets | $46.25 | $117.87 | $126.29 | $151.39 |
| Long term investments | $7.12 | $8.73 | ||
| Property, plant & equipment | $4.01 | $13.09 | $18.19 | $14.03 |
| Goodwill & intangible assets | $1.58 | $17.04 | $17.68 | |
| Total noncurrent assets | $7.71 | $15.57 | $43.5 | $41.15 |
| Total investments | $3.23 | $44.86 | $83.82 | $114.56 |
| Total assets | $53.96 | $133.44 | $169.79 | $192.53 |
| Current liabilities | ||||
| Accounts payable | $2.76 | $4.72 | $7.52 | $8.27 |
| Deferred revenue | ||||
| Short long term debt | $2.58 | $0.32 | $0.4 | $0.93 |
| Total current liabilities | $18.94 | $19.87 | $18.51 | $21.91 |
| Long term debt | $35.9 | $34.43 | $45.01 | $40.15 |
| Total noncurrent liabilities | $35.9 | $38.55 | $45.56 | $44.05 |
| Total debt | $38.48 | $38.86 | $45.4 | $41.08 |
| Total liabilities | $54.84 | $58.42 | $64.07 | $65.95 |
| Shareholders' equity | ||||
| Retained earnings | -$599.98 | -$518.31 | -$478.7 | -$361.01 |
| Other shareholder equity | -$0.87 | -$0.87 | -$0.22 | $0.28 |
| Total shareholder equity | -$0.88 | $75.02 | $105.73 | $126.58 |
| (in millions $) | 31 Mar 2024 | 31 Dec 2023 | 30 Sep 2023 | 30 Jun 2023 |
|---|---|---|---|---|
| Revenue | ||||
| Total revenue | $3.63 | -$7.53 | $5.24 | $5.29 |
| Cost of revenue | $3.65 | -$13.15 | $8.6 | $8.06 |
| Gross Profit | -$0.03 | $5.61 | -$3.36 | -$2.77 |
| Operating activities | ||||
| Research & development | -$14.23 | $4.79 | $6.8 | |
| Selling, general & administrative | $3.34 | -$12.21 | $7.43 | $9.28 |
| Total operating expenses | $0.55 | -$30.07 | $9.58 | $14.47 |
| Operating income | -$0.57 | $35.69 | -$12.94 | -$17.25 |
| Income from continuing operations | ||||
| EBIT | -$0.14 | -$32.23 | -$11.75 | -$16.95 |
| Income tax expense | -$0.01 | $0.07 | ||
| Interest expense | $1.48 | $1.54 | $1.41 | $1.4 |
| Net income | ||||
| Net income | -$1.62 | -$33.77 | -$13.24 | -$18.35 |
| Income (for common shares) | -$1.62 | -$33.77 | -$13.24 | -$18.35 |
| (in millions $) | 31 Dec 2023 | 31 Dec 2022 | 31 Dec 2021 | 31 Dec 2020 |
|---|---|---|---|---|
| Revenue | ||||
| Total revenue | $7.16 | $16.36 | $17.26 | $8.46 |
| Cost of revenue | $10.3 | $31.91 | $32.92 | $15.89 |
| Gross Profit | -$3.14 | -$15.55 | -$15.66 | -$7.42 |
| Operating activities | ||||
| Research & development | $3.48 | $28.15 | $36.68 | $33.45 |
| Selling, general & administrative | $14.07 | $47.65 | $63.52 | $50.36 |
| Total operating expenses | $8.47 | $10.74 | $100.21 | $83.81 |
| Operating income | -$11.61 | -$26.29 | -$115.87 | -$91.24 |
| Income from continuing operations | ||||
| EBIT | -$75.94 | -$34.38 | -$112.01 | -$96.45 |
| Income tax expense | $0.06 | $0.08 | $0.02 | |
| Interest expense | $5.66 | $5.15 | $5.68 | $5.51 |
| Net income | ||||
| Net income | -$81.66 | -$39.62 | -$117.68 | -$101.98 |
| Income (for common shares) | -$81.66 | -$39.62 | -$117.68 | -$101.98 |
| (in millions $) | 31 Mar 2024 | 31 Dec 2023 | 30 Sep 2023 | 30 Jun 2023 |
|---|---|---|---|---|
| Net income | -$1.62 | -$33.77 | -$13.24 | -$18.35 |
| Operating activities | ||||
| Depreciation | $0.26 | -$3.29 | $1.25 | $1.4 |
| Business acquisitions & disposals | $7.3 | |||
| Stock-based compensation | $0.2 | -$1.88 | $1.28 | $1.74 |
| Total cash flows from operations | -$16.93 | -$18.01 | -$14.01 | -$14.58 |
| Investing activities | ||||
| Capital expenditures | -$0.1 | $1.18 | -$0.41 | -$0.75 |
| Investments | $1.75 | $11.26 | $17.36 | $15.89 |
| Total cash flows from investing | $9.23 | $11.22 | $16.95 | $15.14 |
| Financing activities | ||||
| Dividends paid | ||||
| Sale and purchase of stock | $0.28 | -$0.01 | -$0.02 | |
| Net borrowings | -$0.49 | |||
| Total cash flows from financing | -$0.04 | -$0.49 | -$1.94 | -$0.02 |
| Effect of exchange rate | $2.37 | $0.05 | -$0.35 | |
| Change in cash and equivalents | -$7.74 | $1.06 | $0.18 | |
| (in millions $) | 31 Dec 2023 | 31 Dec 2022 | 31 Dec 2021 | 31 Dec 2020 |
|---|---|---|---|---|
| Net income | -$81.66 | -$39.62 | -$117.68 | -$101.98 |
| Operating activities | ||||
| Depreciation | $0.87 | $7.13 | $6.89 | $3.9 |
| Business acquisitions & disposals | $17 | $70 | ||
| Stock-based compensation | $3.03 | $9.39 | $13.75 | $12.1 |
| Total cash flows from operations | -$63.12 | -$85.03 | -$99.68 | -$85.17 |
| Investing activities | ||||
| Capital expenditures | -$0.22 | -$3.98 | -$9.97 | -$11.22 |
| Investments | $42.98 | $38.73 | $29.04 | -$52.6 |
| Total cash flows from investing | $58.55 | $104.75 | $19.07 | -$63.82 |
| Financing activities | ||||
| Dividends paid | ||||
| Sale and purchase of stock | $0.03 | $0.17 | $83.81 | $166.92 |
| Net borrowings | -$0.49 | -$11.41 | ||
| Total cash flows from financing | -$2.66 | -$12.12 | $79.57 | $164.43 |
| Effect of exchange rate | $2.08 | -$0.47 | -$0.12 | $0.34 |
| Change in cash and equivalents | $7.13 | -$1.16 | $15.78 | |
News
Fundamentals
| Market cap | N/A |
|---|---|
| Enterprise value | N/A |
| Shares outstanding | N/A |
| Revenue | $6.62M |
|---|---|
| EBITDA | -$61.45M |
| EBIT | -$61.08M |
| Net Income | -$66.97M |
| Revenue Q/Q | -13.07% |
| Revenue Y/Y | -60.72% |
| P/E ratio | N/A |
|---|---|
| EV/Sales | N/A |
| EV/EBITDA | N/A |
| EV/EBIT | N/A |
| P/S ratio | N/A |
| P/B ratio | N/A |
| Book/Share | N/A |
| Cash/Share | N/A |
| EPS | N/A |
|---|---|
| ROA | -95.45% |
| ROE | -379.70% |
| Debt/Equity | -62.39 |
|---|---|
| Net debt/EBITDA | -0.44 |
| Current ratio | 3.48 |
| Quick ratio | 2.89 |